There was no history of maternal fever, vaginal purulent discharge, or any complication before, during, or after birth.
Objective To determine whether the reported association of maternal fever with neonatal encephalopathy is independent of other associated intrapartum risk factors.
Conclusion: Prolonged antenatal betamethasone therapy was not associated with higher risks of antenatal maternal fever, chorioamnionitis, reduced birth weight, neonatal adrenal suppression, neonatal sepsis, and neonatal death.
There is great variation in the prevalence of reported signs of both intrapartum asphyxia and maternal fever between Bangladesh and India.
The only complication of pregnancy or delivery was maternal fever 5 days prior to delivery that was treated with antibiotics.
Clinically, chorioamnionitis can be diagnosed by maternal fever (>38°C) and 2 of the following: maternal leukocytosis (>15 × 10cells/mm), maternal tachycardia (>100 bpm), fetal tachycardia (>160 bpm), uterine tenderness, and foul-smelling amniotic fluid (1 ).
Maternal fever during delivery was defined as a temperature of 38.0°C or higher, as measured during labor and delivery.
For example maternal fever in labour is associated with an increased risk of cerebral palsy (Grether and Nelson, 1997).
CA manifests clinically as maternal fever, maternal and fetal tachycardia, uterine tenderness, abnormal vaginal discharge, and leukocytosis.
Maternal fever during labor only occurred in 4 cases (1%).
